Healthpeak Properties (DOC) – Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of Healthpeak Properties (NYSE: DOC) recently:

• 7/15/2026 – Healthpeak Properties had its price target raised by Wells Fargo & Company from $20.00 to $22.00. They now have an “equal weight” rating on the stock.
• 7/8/2026 – Healthpeak Properties had its price target raised by UBS Group AG from $19.00 to $21.50. They now have a “neutral” rating on the stock.
• 7/7/2026 – Healthpeak Properties is now covered by Barclays PLC. They set an “equal weight” rating and a $23.00 price target on the stock.
• 7/6/2026 – Healthpeak Properties had its price target raised by Mizuho from $21.00 to $24.00. They now have an “outperform” rating on the stock.
• 6/24/2026 – Healthpeak Properties had its price target raised by JPMorgan Chase & Co. from $18.00 to $21.00. They now have a “neutral” rating on the stock.
• 6/17/2026 – Healthpeak Properties is now covered by Raymond James Financial, Inc.. They set a “market perform” rating on the stock.
• 6/15/2026 – Healthpeak Properties had its price target raised by BMO Capital Markets from $20.00 to $24.00. They now have an “outperform” rating on the stock.
• 6/11/2026 – Healthpeak Properties had its “equal weight” rating reaffirmed by Morgan Stanley. They now have a $22.00 price target on the stock, up from $20.00.
• 6/1/2026 – Healthpeak Properties had its price target raised by Wells Fargo & Company from $18.00 to $20.00. They now have an “equal weight” rating on the stock.
• 5/27/2026 – Healthpeak Properties had its price target raised by Scotiabank from $19.00 to $21.00. They now have a “sector perform” rating on the stock.
• 5/22/2026 – Healthpeak Properties had its price target raised by Morgan Stanley from $18.00 to $20.00. They now have an “overweight” rating on the stock.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.5%. Healthpeak Properties’s payout ratio is currently 381.25%.

Insider Buying and Selling

In other news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.23% of the stock is owned by company insiders.

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.